Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

87.87USD
19 Aug 2019
Change (% chg)

$0.90 (+1.03%)
Prev Close
$86.97
Open
$87.71
Day's High
$88.23
Day's Low
$87.31
Volume
344,402
Avg. Vol
575,034
52-wk High
$88.28
52-wk Low
$61.06

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $43,859.18
Shares Outstanding(Mil.): 510.17
Dividend: 0.22
Yield (%): 1.02

Financials

  BAX.N Industry Sector
P/E (TTM): 34.16 33.28 33.85
EPS (TTM): 2.52 -- --
ROI: -- 14.10 12.69
ROE: -- 64.83 17.13

U.S. closes IV solution shortage antitrust probe, Baxter says

Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices.

Feb 22 2019

U.S. closes IV solution shortage antitrust probe, Baxter says

Feb 22 Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices.

Feb 22 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates